| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000032724 |
| Receipt No. | R000037277 |
| Scientific Title | Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure. |
| Date of disclosure of the study information | 2018/05/25 |
| Last modified on | 2019/05/27 (Ver. 3) |
| Basic information | ||
| Public title | Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure. | |
| Acronym | Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure. | |
| Scientific Title | Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure. | |
| Scientific Title:Acronym | Clinical Value of Liver Stiffness measured by Magnetic Resonance Elastography in Patients with Heart Failure. | |
| Region |
|
|
| Condition | ||||
| Condition | heart failure | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | This study sought to clarify the correlation of CVP and liver stiffness measured by MR elastography, and determine the relationship between liver stiffness and the prognosis of heart failure. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | 1. the correlation of CVP and liver stiffness measured by MR elastography in heart failure patients
2. the relationship between liver stiffness measured by MR elastography and the prognosis of heart failure (all cause death, re-hospitalization for heart failure). |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. heart failure group
Heart failure patients admitted to Hokkaido University Hospital. 2. non heart failure group A person who has no apparent history of heart failure at the time of participation in research at Hokkaido University Hospital. * The definition of "heart failure" in this study shall be in accordance with the guidelines published by the European Society of Cardiology in 2016. |
|||
| Key exclusion criteria | 1. Patients who have organic liver disease such as chronic liver injury, liver cirrhosis, hepatocellular carcinoma
2. Patients who are inappropriate for MRI imaging 3. Patients who are judged to be inappropriate as the research subject by the research staff |
|||
| Target sample size | 330 | |||
| Research contact person | |||||||
| Last name of lead principal investigator |
|
||||||
| Organization | Hokkaido University Hospital | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 0608648 | ||||||
| Address | Kita15 Nishi7,Kita-ku,Sapporo,Hokkaido | ||||||
| TEL | 011-706-6973 | ||||||
| anzai@med.hokudai.ac.jp | |||||||
| Public contact | |||||||
| 1st name of contact person |
|
||||||
| Organization | Hokkaido University Hospital | ||||||
| Division name | Department of Cardiovascular Medicine | ||||||
| Zip code | 0608648 | ||||||
| Address | Kita15 Nishi7,Kita-ku,Sapporo,Hokkaido | ||||||
| TEL | 011-706-6973 | ||||||
| Homepage URL | |||||||
| tnagai@med.hokudai.ac.jp | |||||||
| Sponsor | |
| Institute | Hokkaido University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Hokkaido University Hospital Clinical Research and Medical Inovation Center |
| Address | Kita 14, Nishi 5, Kita-ku, Sapporo, Hokkaido, 060-8648 Japan |
| Tel | 011-706-7061 |
| crjimu@huhp.hokudai.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | prospective observational study |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000037277 |